Total synthesis of phoslactomycin A.
Christian M König1, Björn Gebhardt, Cornelia Schleth
1Fachbereich Chemie, Philipps-University Marburg, Hans-Meerwein-Strasse, D-35032 Marburg, Germany.
Researchers achieved a total synthesis of phoslactomycin A, a protein phosphatase 2A (PP2A) inhibitor. This involved a key copper-catalyzed coupling of two complex fragments, enabling the creation of this important pharmaceutical compound.
Area of Science:
- Organic Synthesis
- Medicinal Chemistry
- Chemical Biology
Background:
- Phoslactomycin A is a potent inhibitor of protein phosphatase 2A (PP2A).
- PP2A plays a critical role in various cellular processes, and its dysregulation is implicated in diseases like cancer.
- A reliable synthetic route to phoslactomycin A is essential for further biological investigation and potential therapeutic development.
Purpose of the Study:
- To develop a convergent total synthesis of the PP2A inhibitor phoslactomycin A.
- To establish key synthetic strategies for assembling complex molecular architectures.
Main Methods:
- Convergent synthesis utilizing a copper(I) thiophene-2-carboxylate (CuTC)-mediated coupling.
- Construction of the C1-C13 fragment via asymmetric dihydroxylation, Evans-Aldol reaction, and protective group strategies.
- Preparation of the C14-C21 fragment through asymmetric 1,4-addition to cyclohexenone.
Main Results:
- Successful execution of a convergent total synthesis of phoslactomycin A.
- Efficient coupling of the C1-C13 alkenyl iodide and C14-C21 alkenyl stannane fragments.
- Demonstration of robust synthetic methodologies applicable to complex natural product synthesis.
Conclusions:
- The developed synthetic route provides access to phoslactomycin A.
- The employed strategies highlight the power of modern organic synthesis in constructing biologically relevant molecules.
- This synthesis facilitates further studies on phoslactomycin A's mechanism of action and therapeutic potential.
More Related Videos
09:08From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü6028
Published on: January 13, 2017
07:59A High-Yield Streptomyces Transcription-Translation Toolkit for Synthetic Biology and Natural Product Applications
Published on: September 10, 2021
Related Concept Videos
Production of Antibiotics
Production of Pharmaceuticals
Peptidoglycan Synthesis
Bacterial Phylum Planctomycetes
Biosynthesis in Bacteria
Combined Effects of Drugs: Synergism
Such synergistic combinations...
